UNSPSC 51131629: Clopidogrel

This classification denotes a thienopyridine antiplatelet agent with the molecular formula C16H16ClNO2S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier A74586SNO7, chemically known as thieno(3,2-c)pyridine-5(4h)-acetic acid, alpha-(2-chlorophenyl)-6,7-dihydro-, methyl ester, (s)- but generally known as clopidogrel, which bears US NIH Compound Identifier 60606. European Medicines Agency schedules Clopidogrel in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB13395MIG.

UNSPSC 51131629 Clopidogrel, a Commodity code, addresses pharmaceutical procurement by state and local governments, but the recent solicitation activity under this code does not reflect pharmaceutical purchasing. Sourcewell, a Minnesota local government cooperative, posted RFP #061626 in May 2026 tagged to this code; however, the solicitation seeks law enforcement equipment, not clopidogrel or any pharmaceutical product. The mismatch suggests either a coding error in the opportunity posting or that the code is being used inconsistently by the issuing cooperative. Based on the available sourced opportunity, the code shows no relevant recent state and local procurement activity for the pharmaceutical product it nominally identifies.

The Sourcewell RFP #061626 (due June 16, 2026) is structured as a cooperative purchasing vehicle under Minnesota law and Washington's RCW 39.34, serving participating entities across multiple Washington counties—Franklin, Grant, Grays Harbor, Chelan, and Yakima—plus jurisdictions throughout the United States and Canada. The procurement targets thousands of governmental agencies, school districts, nonprofit organizations, tribal governments, and other public entities seeking a standardized contracting framework for law enforcement equipment. Because this opportunity does not align with clopidogrel procurement, firms pursuing pharmaceutical sales to state and local buyers should treat this code as currently inactive for its intended scope and monitor alternative pharmaceutical or medical-supply codes for relevant state and local solicitations.